1. Home
  2. BDSX vs ANTX Comparison

BDSX vs ANTX Comparison

Compare BDSX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.87

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$3.55

Market Cap

135.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
ANTX
Founded
2005
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
135.4M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
BDSX
ANTX
Price
$14.87
$3.55
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$32.50
$2.00
AVG Volume (30 Days)
131.3K
3.4M
Earning Date
05-12-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
32.56
EPS
N/A
N/A
Revenue
$88,499,000.00
N/A
Revenue This Year
$25.26
N/A
Revenue Next Year
$19.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.08
N/A
52 Week Low
$0.25
$1.00
52 Week High
$20.21
$6.91

Technical Indicators

Market Signals
Indicator
BDSX
ANTX
Relative Strength Index (RSI) 48.80 54.76
Support Level $6.33 $1.05
Resistance Level $20.21 $6.91
Average True Range (ATR) 1.49 0.86
MACD -0.54 -0.17
Stochastic Oscillator 8.41 3.46

Price Performance

Historical Comparison
BDSX
ANTX

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

Share on Social Networks: